All updates
All updates
today 254Nature Medicine评分6060 Nature Medicine精选评分6060 MAGIC: an international network for evaluating generative artificial intelligence in global health
Nature Cancer评分5757 Intestinal epithelial GSK3β governs fumarate-dependent neutrophil reprogramming to promote colorectal cancer
bioRxiv Cancer Biology评分5151 Discovering Latent Scientific Concepts through Discrete Representation Learning
bioRxiv Cancer Biology评分5858 Genetic dissection of DNA damage response pathways reveals divergent modulation of PD-1 blockade response in colorectal cancer
bioRxiv Cancer Biology评分3939 CRISPR-Cas9 Editing of Myeloid Lectins Reveals Target-Dependent Transcriptional Remodeling in Tumor-Associated Macrophages
bioRxiv Cancer Biology评分5050 RBFOX2 restrains oncogenic cell plasticity in Group 3 medulloblastoma
STAT News评分3939 STAT+: Can you live longer for $5,500? Longevity clinics are the buzzy new trend at nonprofit hospitals
STAT News评分3737 Opinion: Why the FDA should not approve an ineffective multicancer screening test
STAT News评分3333 Opinion: I’m a doctor. Here’s what I want the public to know about AI tools and health care costs
STAT News评分4141 In this hospital, pulse oximeters went from overestimating to underestimating blood oxygen. Why?
中文产业新闻精选Chinese source评分6868 四川大学华西医院团队在Cell发文揭示货物交联驱动AP-1晶格组装的结构机制
中文产业新闻Chinese source评分6969 光遗传学先驱Karl Deisseroth获2026年诺贝尔生理学或医学奖
监管与产业动态精选评分7373 Vaxcyte’s Phase III data strengthen case for broader pneumococcal coverage
监管与产业动态精选评分7272 Building again in rare diseases, Shionogi pays $2B for IntraBio
监管与产业动态精选评分6464 CSL buys into Alentis’ lead autoimmune program for $355M: Deals Report
监管与产业动态精选评分8080 Nobel Prize for optogenetics arrives as first therapy nears FDA decision
监管与产业动态评分3838 Scaling up an innovation culture: a Q&A with argenx’s Karen Massey
监管与产业动态评分2525 China deals, Beam lawsuit, MFN models, Nobel winners — a BioCentury podcast
监管与产业动态评分3333 Fierce Biotech Fundraising Tracker '26: KymaThera corrals $80M; RougeTx lifts off with $58M - Fierce Biotech
监管与产业动态精选评分6262 FDA signs off on first heart valve designed to dynamically expand in children - Fierce Biotech
监管与产业动态评分1111 From Pilots to Practice: Scaling AI Across Clinical Trials - Fierce Pharma
监管与产业动态评分4747 CSL pays $355M to co-develop Alentis’ phase 2-stage fibrosis drug - Fierce Biotech
监管与产业动态评分3636 Genmab’s latest phase 2 data spur claim ADC is ‘clearly superior’ to AbbVie’s Elahere - Fierce Biotech
监管与产业动态评分3737 Candy-coated Lollylab checks saliva for medication
监管与产业动态评分3737 Medetomidine: The dangerous animal sedative turning up in Scotland's street drugs
监管与产业动态评分1717 FDA dings Evolus for blurring the lines between Botox rival and lipstick - Fierce Pharma
监管与产业动态评分3131 Placenta redirects immune cells to support early pregnancy development, study finds
监管与产业动态评分2121 Meet Motivista: Click Therapeutics debuts first-of-its-kind schizophrenia digital therapeutic - Fierce Biotech
监管与产业动态评分1616 Introducing Fierce Biotech's 2026 Fierce 15 - Fierce Biotech
监管与产业动态评分7171 Trio of scientists who developed neuron light switches win Nobel Prize in Physiology or Medicine - Fierce Biotech
监管与产业动态评分3030 Novo flags FDA hemophilia review extension tied to manufacturing site corrections - Fierce Pharma
监管与产业动态精选评分4242 Gate CEO sees expanded $870M pact with Lilly as ‘vote of confidence’ in biotech’s platform - Fierce Biotech
监管与产业动态评分5252 No detectable increase in pregnancy risks after GLP-1 exposure around conception, largest review to date finds
监管与产业动态精选评分5858 Rare genetic variants linked to lower cognitive test scores in expanded analysis
监管与产业动态评分3030 Vaxcyte’s stock jumps as pneumococcal vaccine holds its own against Pfizer's, Merck’s shots - Fierce Biotech
监管与产业动态精选评分6464 One dose of protein-targeting CAR-T cells shrinks solid tumors in preclinical tests
监管与产业动态评分3737 Scientists study breast milk as an early detection tool for breast cancer
监管与产业动态评分1818 BridgeBio taps Hip Hop Public Health and others up to put a new beat on ATTR-CM awareness - Fierce Pharma
监管与产业动态评分4242 Genentech pays Alector $100M for preclinical Parkinson’s prospect - Fierce Biotech